Rhinosectan® spray (containing xyloglucan) on the ciliary function of the nasal respiratory epithelium; Results of an in vitro study

Allergy, Asthma and Clinical Immunology

Volumn 14, Issue 1, 2018, Pages

  Piqué, Núria ^a   De Servi, Barbara ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b In Vitro Research Laboratories   (Italy)

Author keywords

Allergy; Barrier properties; Ciliary function; Medical devices; Mucin secretion; Mucociliary clearance; Nasal obstruction; Preventive measures; Rhinitis; Rhinosinusitis; Xyloglucan

Indexed keywords

EID: 85054868423     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/s13223-018-0268-3     Document Type: Article

References (35)

1. Piqué N, Gómez-Guillén MDC, Montero MP. Xyloglucan, a plant polymer with barrier protective properties over the mucous membranes: an overview. Int J Mol Sci. 2018;19(3):673. https://doi.org/10.3390/ijms19030673.
2. Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16:1024-33.
3. Oshima T, Miwa H. Gastrointestinal mucosal barrier function and diseases. J Gastroenterol. 2016;51:768-78.
4. Andersson M, Greiff L, Ojeda P, Wollmer P. Barrier-enforcing measures as treatment principle in allergic rhinitis: a systematic review. Curr Med Res Opin. 2014;30:1131-7.
5. ® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study. Allergy Asthma Clin Immunol. 2017;12:37.
6. Rezaee F, DeSando SA, Ivanov AI, Chapman TJ, Knowlden SA, Beck LA, et al. Sustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption. J Virol. 2013;87:11088-95.
7. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010. J Allergy Clin Immunol. 2010;126:466-76.
8. Ojeda P, Piqué N, Alonso A, Delgado J, Feo F, Igea JM, et al. A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study). Allergy Asthma Clin Immunol. 2013;9:32.
9. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;328:2112-22.
10. Allegrini A, Pavone D, Carluccio F. A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis. Curr Med Res Opin. 2018;34:377-85.
11. ® (containing gelatin-xyloglucan) against Escherichia coli invasion of intestinal epithelial cells. Results of an in vitro study. Fut Microbiol. 2016;11:651-8.
12. Fraile B, Alcover J, Royuela M, Rodríguez D, Chaves C, Palacios R, et al. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies. Fut Microbiol. 2017;12:721-31.
13. Bueno L, Theodorou V, Sekkal S. Xyloglucan: a new agent to protect the intestinal mucosa and to prevent bacterially mediated alteration of tight junction permeability. 22nd United European Gastroenterology (UEG) week; 2014. Abstract P1675.
14. Gnessi L, Bacarea V, Marusteri M, Piqué N. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. BMC Gastroenterol. 2015;15:153.
15. Plesea Condratovici C, Bacarea V, Piqué N. Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized controlled, clinical trial. Gastroenterol Res Pract. 2016;2016:6874207.
16. Jiao J, Meng N, Zhang L. The effect of topical corticosteroids, topical antihistamines, and preservatives on human ciliary beat frequency. ORL J Otorhinolaryngol Relat Spec. 2014;76:127-36.
17. BéruBé K, Aufderheide M, Breheny D, Clothier R, Combes R, Duffin R, et al. In vitro models of inhalation toxicity and disease. The report of a FRAME workshop. Altern Lab Anim. 2009;37:89-141.
18. Iskandar AR, Xiang Y, Frentzel S, Talikka M, Leroy P, Kuehn D, et al. Impact assessment of cigarette smoke exposure on organotypic bronchial epithelial tissue cultures: a comparison of mono-culture and coculture model containing fibroblasts. Toxicol Sci. 2015;147:207-21.
19. Burgener A, McGowan I, Klatt NR. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. Curr Opin Immunol. 2015;36:22-30.
20. Scadding GK. Optimal management of allergic rhinitis. Arch Dis Child. 2015;100:576-82.
21. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic rhinitis and its impacto n asthma (ARIA) guidelines-2016 revision. J allergy Clin Immunol. 2017;140:950-8.
22. Boek WM, Keleş N, Graamans K, Huizing EH. Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope. 1999;109:396-9.
23. Hofmann T, Gugatschga M, Koidl B, Wolf G. Influence of preservatives and topical steroids on ciliary beat frequency in vitro. Arch Otolaryngol Head Neck Surg. 2004;130:440-5.
24. Homer JJ, Dowley AC, Condon L, El-Jassar P, Sood S. The effect of hypertonicity on nasal mucociliary clearance. Clin Otolaryngol Allied Sci. 2000;25:558-60.
25. Cohen NA. Sinonasal mucociliary clearance in health and disease. Ann Otol Rhinol Laryngol Suppl. 2006;196:20-6.
26. Bascom R, Kesavanathan J, Fitzgerald TK, Cheng KH, Swift DL. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect. 1995;103:1026-30.
27. Thornton DJ, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc. 2004;1:54-61.
28. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002;109:571-7.
29. Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459-86.
30. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86:245-78.
31. Hayashi T, Ishii A, Nakai S, Hasegawa K. Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic asthmatic airway inflammation in a mouse model of asthma in vivo. Virchows Arch. 2004;444:66-73.
32. Hays SR, Fahy JV. The role of mucus in fatal asthma. Am J Med. 2003;115:68-9.
33. Bossé Y, Riesenfeld EP, Paré PD, Irvin CG. It's not all smooth muscle: non-smooth-muscle elements in control of resistance to airflow. Annu Rev Physiol. 2010;72:437-62.
34. Seagrave J, Albrecht HH, Hill DB, Rogers DF, Solomon G. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells. Respir Res. 2012;13:98.
35. Abanses JC, Arima S, Rubin BK. Vicks VapoRub induces mucin secretion, decreases ciliary beat frequency, and increases tracheal mucus transport in the ferret trachea. Chest. 2009;135:143-8. https://doi.org/10.1378/chest.08-0095.